ENTOD Pharmaceuticals receives CDSCO approval for paediatric myopia treatment
The formulation, approved following Phase 3 trials in India, becomes the first globally authorised treatment strength for slowing…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Central Drugs Standard Control Organisation (CDSCO)
Shilpa Medicare receives CDSCO SEC Nod for IND Nor UDCA tablets for NAFLD treatment
Shilpa Medicare secures Subject Expert Committee approval for its novel therapy Nor Ursodeoxycholic Acid, following positive phase…
Dr Raghuvanshi reappointed as Drugs Controller General of India for one year
The Appointments Committee of the Cabinet approves re-employment of Dr Rajeev Singh Raghuvanshi on a contractual basis, effective…
Pharma’s strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it’s a space where the allure of a $11.55…
Sanofi India receives marketing authorisation for Rezurock in India
Belumosudil Tablets approved for chronic graft-versus-host disease treatment